Log In
BCIQ
Print this Print this
 

MP0260

  Manage Alerts
Collapse Summary General Information
Company Molecular Partners AG
DescriptionDesigned ankyrin repeat protein (DARPin) that inhibits platelet derived growth factor B (PDGFB; PDF2) and vascular endothelial growth factor A (VEGF-A)
Molecular Target Platelet derived growth factor B (PDGFB) (PDGF2) ; Vascular endothelial growth factor A (VEGF-A)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat wet age-related macular degeneration (AMD)
Regulatory Designation
PartnerAllergan plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$420.0M

$45.0M

$375.0M


 Deals Details
Get a free BioCentury trial today